21 Feb Croatia among the first three EU countries that introduced mobile apps for ADR reporting
At the conference “Next Generation Pharmacovigilance”, held on 18 May 2016 in Zagreb, Agency for Medicinal Products and Medical Devices (HALMED) presented the mobile application for the reporting of suspected adverse drug reactions (ADR reporting). HALMED is among the first three European medicinal product agencies that introduced applications for ADR reporting via smartphones. The mobile application is meant for patients, health care professionals, carers and others so that they could directly report ADRs as well as receive the latest information concerning medicinal products using their mobile devices.
The mobile application is an alternative to already available ways of reporting ADRs via the online application and paper forms, and its introduction enables ADR reporting on the move as well as easier availability of information on medicinal products.
With this mobile application, HALMED attempts to additionally strengthen the involvement of patients and health care professionals in the monitoring of safe use of medicinal products by enabling a simple and direct way of ADR reporting via smartphones. The users of the application can select particular medicinal products from HALMED’s Medicinal Products Database and keep track of all updates concerning their safe use. Additionally, they can view the reported suspicions of adverse drug reactions for every medicinal product that interests them.
By introducing the mobile application for ADR reporting, HALMED is once again at the forefront of trends as well as application of new information technologies within the European pharmacovigilance system.
Originally published on 18 May 2016 by Agency for Medicinal Products and Medical Devices of Croatia HALMED at http://www.halmed.hr/en/Novosti-i-edukacije/Priopcenja-za-medije/2016/Croatia-among-the-first-three-EU-countries-that-introduced-mobile-apps-for-ADR-reporting/1554